Parental Opioid Use Disorders Market Research Report – Segmented By Drug Class (Buprenorphine, Methadone, Naltrexone); Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, Online Pharmacies, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15020
Format:
Region: Global
Chapter 1. Parental Opioid Use Disorders Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Parental Opioid Use Disorders Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. Parental Opioid Use Disorders Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Parental Opioid Use Disorders Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Parental Opioid Use Disorders Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Parental Opioid Use Disorders Market - By Drug Class
6.1 Methadone
6.2 Naltrexone
6.3 Buprenorphine
Chapter 7. Parental Opioid Use Disorders Market - By Distribution Channel
7.1 Hospital Pharmacies
7.2 Retail Pharmacies & Stores
7.3 Online Pharmacies
7.4 Others
Chapter 8. Parental Opioid Use Disorders Market - By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of the World
Chapter 9. Parental Opioid Use Disorders Market - Key Players
9.1 Indivior PLC (U.S.)
9.2 Alkermes (Ireland)
9.3 Orexo AB (Sweden)
9.4 Titan Pharmaceuticals, Inc. (U.S.)
9.5 Mallinckrodt Pharmaceuticals (U.K.)
9.6 BioDelivery Sciences International Inc. (U.S.)
9.7 Viatris Inc. (Mylan N.V.) (U.S.)
9.8 Hikma Pharmaceuticals PLC (U.K.)
9.9 Camurus (Sweden)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Global Parental Opioid Use Disorders (OUD) Market was estimated to be worth USD 1.94 Billion in 2022 and is projected to reach a value of USD 3.59 Billion by 2030, growing at a CAGR of 8% during the forecast period 2023-2030
The Global Parental Opioid Use Disorders (OUD) Market is driven by the Growing Awareness of the Impact of Parental Substance Abuse on Children.
The Segments under the Global Parental Opioid Use Disorders (OUD) Market by Distribution Channel are Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies.
USA and Canada are the most dominating countries in the Asia Pacific region for the Global Parental Opioid Use Disorders (OUD) Market.
Indivior PLC, Orexo AB, and Camurus are the three major leading players in the Global Parental Opioid Use Disorders (OUD) Market.
